Demographic Profile of Pediatric Malignancies in Himachal Pradesh
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2018; 39(03): 287-291
DOI: DOI: 10.4103/ijmpo.ijmpo_186_16
Abstract
Context: Pediatric malignancy is on the rise worldwide, and it is imperative to know the profile of pediatric malignancy in different geographical areas so as to formulate effective strategy to its control. As there are no data from this part, especially the Himalayan region of North India, the present study was planned. Aims: The aims of this study were to study the pattern and demographic profile of pediatric malignancies at a tertiary care teaching hospital in Himachal Pradesh. Settings and Design: This was a hospital-based, prospective, nonrandomized, observational study. Subjects and Methods: Pattern and demographic profile of clinically suspected malignancies in children and adolescents (0–18 years) over a period of 1 year from June 2012 to May 2013 in the Department of Pediatrics and Radiotherapy. Statistical Analysis Used: Data were analyzed statistically using Epi Info software for all ratios and proportions. Results:: A total of 31 children were diagnosed to have malignancy, which accounted for 0.86% of total admissions with a male-to-female ratio of 1.58:1.The three most common childhood malignancies were leukemia (29.03%), central nervous system (CNS) tumors (25.80%), and lymphoma (19.35%), and these were followed by Wilm's tumor and hepatoblastoma, each accounting for 06.45% of total childhood malignancies. Hematological malignancies accounted for 48.38% and nonhematological malignancies for 51.62% of all the malignancies. Acute lymphoblastic leukemia was the most common hematological malignancy noted in 22.58%, followed equally by Hodgkin's disease and non-Hodgkin's lymphoma (20% of total hematological malignancies). Among nonhematological malignancies, CNS malignancies were the most common. In the age group of 0–5 years, all cases of neuroblastoma, yolk sac tumor, and ovarian tumor and 50%-cases of hepatoblastoma and Wilm's tumor were seen. In the age group of 5–10 years, leukemia (44.44%) was the most common malignancy followed by lymphoma (33.33%). In 14–18 years, CNS malignancies (50%) were the most common malignancies followed by lymphoma (33.33%). Conclusions: Hematological malignancies are the most common malignancies in the pediatric age group, and acute leukemia was the single most common pediatric malignancy, and CNS malignancies were the most common nonhematological malignancies.
Keywords
Himalayas - malignancies - North India - pediatricPublication History
Article published online:
17 June 2021
© 2018. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
Abstract
Context: Pediatric malignancy is on the rise worldwide, and it is imperative to know the profile of pediatric malignancy in different geographical areas so as to formulate effective strategy to its control. As there are no data from this part, especially the Himalayan region of North India, the present study was planned. Aims: The aims of this study were to study the pattern and demographic profile of pediatric malignancies at a tertiary care teaching hospital in Himachal Pradesh. Settings and Design: This was a hospital-based, prospective, nonrandomized, observational study. Subjects and Methods: Pattern and demographic profile of clinically suspected malignancies in children and adolescents (0–18 years) over a period of 1 year from June 2012 to May 2013 in the Department of Pediatrics and Radiotherapy. Statistical Analysis Used: Data were analyzed statistically using Epi Info software for all ratios and proportions. Results:: A total of 31 children were diagnosed to have malignancy, which accounted for 0.86% of total admissions with a male-to-female ratio of 1.58:1.The three most common childhood malignancies were leukemia (29.03%), central nervous system (CNS) tumors (25.80%), and lymphoma (19.35%), and these were followed by Wilm's tumor and hepatoblastoma, each accounting for 06.45% of total childhood malignancies. Hematological malignancies accounted for 48.38% and nonhematological malignancies for 51.62% of all the malignancies. Acute lymphoblastic leukemia was the most common hematological malignancy noted in 22.58%, followed equally by Hodgkin's disease and non-Hodgkin's lymphoma (20% of total hematological malignancies). Among nonhematological malignancies, CNS malignancies were the most common. In the age group of 0–5 years, all cases of neuroblastoma, yolk sac tumor, and ovarian tumor and 50%-cases of hepatoblastoma and Wilm's tumor were seen. In the age group of 5–10 years, leukemia (44.44%) was the most common malignancy followed by lymphoma (33.33%). In 14–18 years, CNS malignancies (50%) were the most common malignancies followed by lymphoma (33.33%). Conclusions: Hematological malignancies are the most common malignancies in the pediatric age group, and acute leukemia was the single most common pediatric malignancy, and CNS malignancies were the most common nonhematological malignancies.
Keywords
Himalayas - malignancies - North India - pediatric
Introduction
In 2008, 7.6 million people died of cancer – 13% of all deaths worldwide. About 70% of all cancer deaths occur in low- and middle-income countries.[1] Worldwide, the annual number of new cases of childhood cancer exceeds 200,000 and more than 80% of these are from the developing world.[2] Cancer remains one of the major causes of death in children between the ages of 0–14 years.[3] Pediatric cancers differ markedly from adult cancers in their nature, distribution, and prognosis. The incidence of childhood cancer and type vary greatly throughout the world. Although lower compared with the incidence of some adult cancers, it comes next to accidents as the leading cause of death among children in the developed world, accounting for 10%–12.3% of all childhood deaths.[3],[4],[5],[6] In 2005, the International Union Against Cancer reported that, worldwide, more than 160,000 children are diagnosed with cancer per year, and about 90,000 die from cancer because of late presentation due to parental ignorance and poverty and poor health facilities.[7] It has also been estimated that more than 85% of childhood cancer cases occurred in resource-poor countries, and it is possible that this will increase to 90% in the next two decades as a result of an expected rapid increase in the youth population.[8] In developing countries like India, childhood mortality is still mainly due to malnutrition and infections, but pediatric tumors are also rising in number.[4] As there is paucity of studies regarding the pattern of childhood malignacies from this part of north India, present study was conducted to ascertain the pattern of childhood malignancies in Himachal Pradesh.
Subjects and Methods
A prospective nonrandomized study was conducted in children (0–18 years) over a period of 1 year from June 2012 to May 2013 in the Department of Pediatrics and Radiotherapy at a tertiary teaching institute in North India. All the children aged ≤18 years with malignancies diagnosed by means of cytological or histopathological examination were enrolled in the study. Written informed consent was obtained from the parents/guardians of all patients. The study was approved by the Institutional Ethics Committee. The profile of childhood cancer was studied focusing on the proportion of malignancies according to (a) age at presentation (divided into four groups, i.e., 0–4 years, 5–9 years, 10–14 years, and 15–18 years), (b) sex, (c) rural and urban distribution, (d) site of origin of tumor, and (e) their histopathological diagnosis.
The cases were assessed clinically by taking relevant history and doing general physical examination. Specific investigations were undertaken to establish the diagnosis of malignancy. Hemoglobin, total leukocyte count, differential leukocyte count, and platelets count were analyzed by “COULTER'S MX-9” autoanalyzer. Bone marrow films were prepared from aspirated material and were stained using Romanowsky stain and examined under microscope. FNAC material obtained was smeared on glass slides fixed in 95% ethyl alcohol for Papanicolaou staining and air dried for Giemsa staining. Excision, incision, and true cut biopsy were done where ever indicated. Specialized stains were used for more accurate diagnoses. Radiological investigations such as X-ray, ultrasound, computed tomography (CT) scans, and magnetic resonance imaging (MRI) were done. Data were analyzed statistically using Epi Info software for all ratios and proportions.
Results
In this study period, out of 3605 children admitted, 31 were diagnosed to have malignancy, which accounted for 0.86% of admission, and a total of 1978 patients (children + adult) were diagnosed to have one or the other malignancy during this period; thus, childhood malignancies (n = 31) constituted 1.57% of total cancer burden. There were 19 males and 12 females. Males were affected (61.29%) more than females (38.71%) with a male-to-female ratio of 1.58:1.
In this study, the three most common childhood malignancies were leukemia (29.03%), central nervous system (CNS) tumors (25.80%), and lymphoma (19.35%) these were followed by Wilm's tumor and hepatoblastoma, each accounting for 06.45% of total childhood malignancies as shown in [Table 1].
Site |
Malignancy |
Number of cases |
---|---|---|
ALL – Acute lymphoblastic leukemia; AML – Acute myeloid leukemia; NHL – Non-Hodgkin lymphoma; HL – Hodgkin lymphoma; CNS – Central nervous system; MC – Mixed cellularity; LP – Lymphocyte predominant |
||
1) Hematological |
||
1a) Leukemia |
||
1aa) ALL |
ALL - L1 |
3 |
ALL - L2 |
4 |
|
1ab) AML |
AML - M2 |
1 |
AML -M3 |
1 |
|
1b) Lymphoma |
||
1ba) NHL |
3 |
|
1bb) HL |
HL-(MC) |
2 |
HL-(LP) |
1 |
|
2) Nonhematological |
||
2a) CNS |
Craniopharyngioma |
3 |
Medulloblastoma |
2 |
|
Meningioma |
1 |
|
Pinealoblastoma |
1 |
|
Thalamic glioma |
1 |
|
2b) Neuroendocrine |
Neuroblastoma |
1 |
2c) Thorax |
Teratoma anterior mediastinum |
1 |
2d) Hepatobiliary |
Hepatoblastoma |
2 |
2e) Renal |
Wilm’s tumor |
2 |
2f) Others |
Yolk sac tumor |
1 |
Ovarian tumor |
1 |
|
All malignancies |
31 |
Serial number |
Malignancy |
Age group |
||||
---|---|---|---|---|---|---|
0-5 years (%) |
5-10 years (%) |
10-14 years (%) |
14-18 years (%) |
Total <18> |
||
CNS – Central nervous system |
||||||
1 |
Hematological |
3 (20.00) |
7 (46.67) |
3 (20.00) |
2 (13.33) |
15 |
a |
Leukemias |
2 (22.22) |
4 (44.45) |
1 (11.11) |
2 (22.22) |
9 |
b |
Lymphomas |
1 (16.67) |
3 (50.00) |
2 (33.33) |
0 |
6 |
2 |
CNS malignancy |
2 (25.00) |
1 (12.50) |
2 (25.00) |
3 (37.50) |
8 |
3 |
Neuroblastoma |
1 (100) |
0 |
0 |
0 |
1 |
4 |
Teratoma anterior mediastinum |
0 |
0 |
0 |
1 (100) |
1 |
5 |
Hepatoblastoma |
1 (50) |
0 |
1 (50) |
0 |
2 |
6 |
Wilm’s tumor |
1 (50) |
1 (50) |
0 |
0 |
2 |
7 |
Yolk sac tumor |
1 (100) |
0 |
0 |
0 |
1 |
8 |
Ovarian tumor |
1 (100) |
0 |
0 |
0 |
1 |
Total |
All malignancies |
10 (32.26) |
09 (29.04) |
6 (19.35) |
6 (19.35) |
31 |
Study |
Place |
Burden (percentage of total malignancies) |
---|---|---|
Rathi et al.[4] |
New Delhi |
3.38 |
Yeole, et al.[11] |
Mumbai |
3.3 |
Jignasa and Mandakini[10] |
Surat (Gujarat) |
2.0 |
Ferlay et al.[12] |
USA |
0.8 |
Arora et al.[2] |
UK |
0.5 |
Present study |
HP |
1.57 |
Tumor |
USA[13] |
UK[14] |
Australia[15] |
India[4] |
Kerala[5] |
Delhi[16] |
Mumbai[11] |
Present study |
---|---|---|---|---|---|---|---|---|
CNS – Central nervous system |
||||||||
Leukemia |
30.1 |
20.4 |
20.6 |
32.00 |
30.0 |
28.8 |
32.80 |
29.03 |
Lymphoma |
12.3 |
8.7 |
10.3 |
14.08 |
10.0 |
11.5 |
12.65 |
19.35 |
CNS tumors |
19.1 |
16.6 |
21.0 |
18.21 |
19.3 |
21.0 |
17.60 |
25.80 |
Neuroblastoma |
8.1 |
7.5 |
7.4 |
4.21 |
5.1 |
4.1 |
- |
03.23 |
Wilm’s tumor |
6.5 |
5.4 |
6.6 |
4.94 |
5.4 |
3.3 |
5.25 |
06.45 |
Bone tumors |
4.8 |
4.8 |
5.3 |
7.66 |
5.4 |
3.3 |
3.85 |
0 |
Soft-tissue tumors |
6.3 |
8.5 |
- |
5.49 |
6.6 |
3.8 |
4.30 |
0 |
Other |
10.1 |
16.0 |
17.1 |
18.35 |
13.8 |
11.8 |
19.00 |
16.13 |
References
- WHO. 10 Facts about Cancer. Available from: http://www.who.int/features/factfiles/cancer/facts/en/index9.html. [Last accessed on 2012 May 03]
- Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer 2009; 46: 264-73
- American Cancer Society. Cancer Facts and Figures; 2005. Available from: http://www.cancer.org [Last reviewed on 2005 Mar 29]
- Rathi AK, Kumar S, Ashu A, Singh K, Bahadur AK. Epidemiology of paediatric tumors at a tertiary care centre. Indian J Med Paediatr Oncol 2007; 28: 343-50
- Kusumakumary P, Jacob R, Jothirmayi R, Nair MK. Profile of pediatric malignancies: A ten year study. Indian Pediatr 2000; 37: 1234-8
- Kusumakumari P. Childhood malignancies. Indian J Med Paediatr Oncol 1996; 17: 168-77
- International Union against Cancer The “My Child Matters” Initiative [press release] Geneva: UICC; 2005 Available from: http://www.uicc.org/index.php?option=com_content&task=view&id=15898&Itemid=43 [Last accessed on 2008 Nov 12]
- Yaris N, Mandiracioglu A, Büyükpamukcu M. Childhood cancer in developing countries. Pediatr Hematol Oncol 2004; 21: 237-53
- Mandong BM, Angyo IA, Zoakah AI. Paediatric solid malignant tumours in JUTH, Jos (hospital based histopathology study). Niger J Med 2000; 9: 52-5
- Jignasa B, Mandakini P. Profile of pediatric malignancy: A three year study. Natl J Community Med 2011; 2: 24-7
- Yeole BB, Advani SH, Sunny L. Epidemiological features of childhood cancers in greater Mumbai. Indian Pediatr 2001; 38: 1270-7
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide Lyon: IARC Press; 2004
- Young JLJr, Miller RW. Incidence of malignant tumors in U. S. Children. J Pediatr 1975; 86: 254-8
- Pearson D, Steward JK. Malignant disease in juveniles. Proc R Soc Med 1969; 62: 685-8
- McWhirter WR, Siskind V. Childhood cancer survival trends in Queensland 1956-80. Br J Cancer 1984; 49: 513-9
- Arya LS. Childhood cancer – Challenges and opportunities. Indian J Pediatr 2003; 70: 159-62
- Joshi V, Kumar A. Pediatric Hemato-Oncology in India Epidemiologic Differences. M.B. Agrawal. Hematology Today; 2004